Imagine being born with a ticking time bomb in your arteries. Not because of poor diet or lack of exercise, but because of a gene you inherited from a parent. This is the reality for people with familial hypercholesterolemia (FH). It’s not rare. It affects about 1 in every 200 to 250 people worldwide. Yet, more than 90% of those people don’t even know they have it. And without knowing, they’re at eight to ten times higher risk of having a heart attack before age 50 - sometimes even before 30.
What Is Familial Hypercholesterolemia?
Familial hypercholesterolemia is a genetic condition that causes dangerously high levels of LDL cholesterol - the "bad" kind - from birth. It’s not caused by eating too much cheese or skipping the gym. It’s caused by a broken gene, usually inherited from one parent (heterozygous FH) or sometimes both (homozygous FH). This gene defect stops the liver from removing LDL cholesterol properly, so it builds up in the blood and sticks to artery walls, causing plaques that can block blood flow.
People with heterozygous FH typically have LDL levels above 190 mg/dL as adults, or over 160 mg/dL as kids. Those with homozygous FH? Their LDL can hit 400 mg/dL or higher. That’s like having a constant flood of cholesterol pouring into your arteries. Left untreated, men with FH lose an average of 30 years of life. Women lose about 25. But here’s the critical part: if you catch it early and treat it hard, life expectancy can return to normal.
Why Most People Never Get Diagnosed
Here’s the scary truth: in the U.S., only 6 to 10% of people with FH are diagnosed. That means over 1.3 million Americans with FH are walking around unaware. Why? Because FH often has no symptoms until it’s too late.
Unlike high blood pressure or diabetes, you can’t feel high cholesterol. And while homozygous FH can show visible signs like yellowish lumps on tendons (xanthomas) or a white ring around the cornea (corneal arcus), heterozygous FH - the more common form - looks completely normal on the outside. The first sign? A heart attack.
Doctors don’t always think to test for it. Pediatricians rarely check cholesterol in kids, even though the American Academy of Pediatrics says every child should be screened between ages 9 and 11. Only 12% of U.S. pediatricians do it regularly. And even when a young adult ends up in the ER after a heart attack, doctors rarely ask about family history - or test for FH.
There’s also a gap in access. Genetic testing, the gold standard for diagnosis, is expensive and not widely available. Many insurance plans won’t cover it unless you already have a strong suspicion. So most people get diagnosed by accident - after a heart event.
How to Spot It: Screening Methods That Work
There are two proven ways to find FH before it kills someone: universal screening and cascade screening.
Universal screening means testing all kids between ages 9 and 11 for cholesterol levels. No exceptions. If a child’s LDL is over 160 mg/dL, they need further evaluation. This method catches kids with FH regardless of family history. It’s simple, cost-effective, and endorsed by the American Heart Association. But in practice? It’s rarely done.
Cascade screening is the smarter way to find more cases fast. Once one person is diagnosed with FH, you test their first-degree relatives - parents, siblings, kids. Since FH is autosomal dominant, each of those relatives has a 50% chance of having it too. Then you test the relatives of those relatives. One diagnosis can lead to five, ten, even twenty more.
In the Netherlands, where cascade screening has been mandatory for decades, over 18,000 cases have been found. In the U.S.? Only 30-40% of eligible families even get screened. And even then, only 2.9% of diagnosed adults actually get their relatives tested, according to a 2022 Circulation study.
Tools like the Dutch Lipid Clinic Network (DLCN) criteria help doctors decide who to test based on cholesterol levels, family history, and physical signs. But new tech is changing the game. Machine learning models now analyze electronic health records - age, sex, LDL levels, family history - and flag potential FH cases with 92% accuracy. One 2023 study showed these AI tools cut the number of people you need to screen by nearly half.
Aggressive Treatment: It’s Not Optional
Once FH is diagnosed, treatment can’t wait. The goal isn’t just to lower cholesterol - it’s to prevent heart attacks before they happen. And that means starting early and going hard.
For children with FH, statins are recommended as early as age 2 if one parent has it, or at birth if both do. Statins reduce LDL by 30-50% and have been proven safe in kids over decades of use. But most people don’t stop there. For adults and high-risk kids, combining statins with ezetimibe (a pill that blocks cholesterol absorption) or PCSK9 inhibitors (injections that help the liver clear LDL) is standard.
PCSK9 inhibitors like evolocumab and inclisiran are game-changers. Inclisiran, approved in 2021, only needs two shots a year. That’s huge for adherence - many people forget daily pills, but two shots? Much easier to stick with.
The target? Get LDL below 100 mg/dL for adults, and below 135 mg/dL for children. And it’s not enough to just hit the number - you need to cut LDL by at least 50% from its original level. That’s aggressive. But necessary. Studies show people who stick to this plan can live as long as anyone else.
Why This Isn’t Happening Everywhere
So why aren’t we doing this everywhere? Three big reasons.
First, awareness. Many doctors still think high cholesterol is a lifestyle issue. They don’t recognize FH as a genetic emergency. Second, access. There’s one lipid specialist for every 1.5 million people in the U.S. Most patients never see one. Third, cost. Genetic tests cost hundreds to thousands of dollars. Insurance often denies them. And even when they’re approved, labs take weeks to return results.
Meanwhile, countries like the Netherlands, the UK, and Norway have national FH registries. They track every case, mandate cascade screening, and fund genetic testing. Their diagnosis rate? 20-30%. In the U.S.? Still stuck at 6-10%.
And the cost of doing nothing? The CDC estimates that without action, 250,000 Americans will die prematurely from FH-related heart disease in the next decade. But if we implemented full cascade screening and early treatment, we could prevent 180,000 of those deaths.
What You Can Do Right Now
If you’ve had a heart attack before 50 - or if a close relative did - get tested. Don’t wait. Ask for an LDL test. If your level is over 190 (or 160 if you’re a kid), push for further evaluation. Request genetic testing if possible.
If you’re a parent: get your child’s cholesterol checked between ages 9 and 11. Even if they’re thin, active, and eat healthy. FH doesn’t care.
If you’re a doctor: screen your pediatric patients. Test family members of diagnosed patients. Use the DLCN criteria. Don’t wait for symptoms. Don’t assume it’s just "bad cholesterol."
FH isn’t a lifestyle disease. It’s a genetic emergency. And the tools to fix it already exist. We know how to find it. We know how to treat it. We just need to start doing it - consistently, aggressively, and without delay.
Write a comment